Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer

Clinical trial NCT03759600 · COMPLETED

Trial details

NCT number: NCT03759600
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2018-12-26
Primary completion: 2022-12-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.